Literature DB >> 16324564

[Early indicators of severity in dengue virus infection].

Fredi Alexander Díaz-Quijano1, Ruth Aralí Martínez-Vega, Luis Angel Villar-Centeno.   

Abstract

OBJECTIVE: To identify clinical markers of severity in dengue, different from those of major hemorrhage.
DESIGN: Cross-sectional study. POPULATION AND METHODS: Patients with a diagnosis of dengue infection admitted to hospitals in Santander (Colombia) during the years 1993 to 1998 were studied. On admittance or during hospitalization, patients were classified as cases of dengue hemorrhagic fever (DHF) or dengue fever (DF). Clinical findings differing from those of major hemorrhage were recorded in the emergency room and during the first assessment at hospitalization. The association between these findings and the outcome of DHF were evaluated using univariate and multivariate analyses.
RESULTS: 891 patients (DF: 420; DHF: 471) were included in the study. Associations were found between DHF and the following signs and symptoms: vomiting (OR: 1.89; 95% CI: 1.37-2.6; p = 0.0001); gingival hemorrhage (OR: 1.55; 95% CI: 1.11-2.18; p = 0.01); epistaxis (OR: 1.78; 95% CI: 1.28-2.48; p = 0.001); hepatomegaly (OR: 2.56; 95% CI: 1.61-4.07; p < 0.0001); microscopic hematuria (OR: 2.33; 95% CI: 1.36-4; p = 0.002); and rash (OR: 1.36; 95% CI: 1.04-1.77; p = 0.02). The hematocrit in the emergency room and on the first day of hospitalization was significantly higher in the group with DHF (p < 0.001, in both observations). On multivariate analysis, the hematocrit from DHF patients obtained in the emergency room was higher than that from DF, independently of the other relevant variables (difference: 3.65; 95% CI: 2.81-4.49).
CONCLUSION: Under the study conditions, there was an association between early clinical findings and DHF. These results must be evaluated in a cohort study.

Entities:  

Mesh:

Year:  2005        PMID: 16324564     DOI: 10.1157/13080262

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  8 in total

1. 

Authors:  Lluís Valerio; M Dolors Tenas; Sílvia Roure
Journal:  FMC       Date:  2009-01-06

2.  Serum fatty acids and progression from dengue fever to dengue haemorrhagic fever/dengue shock syndrome.

Authors:  Eduardo Villamor; Luis A Villar; Anyela Lozano-Parra; Víctor M Herrera; Oscar F Herrán
Journal:  Br J Nutr       Date:  2018-08-14       Impact factor: 3.718

3.  Simple Prognostic Criteria can Definitively Identify Patients who Develop Severe Versus Non-Severe Dengue Disease, or Have Other Febrile Illnesses.

Authors:  Andrew K I Falconar; Claudia M E Romero-Vivas
Journal:  J Clin Med Res       Date:  2012-01-17

4.  A predictive model to differentiate dengue from other febrile illness.

Authors:  Eduardo Fernández; Marek Smieja; Stephen D Walter; Mark Loeb
Journal:  BMC Infect Dis       Date:  2016-11-22       Impact factor: 3.090

5.  Vitamin D serostatus and dengue fever progression to dengue hemorrhagic fever/dengue shock syndrome.

Authors:  E Villamor; L A Villar; A Lozano; V M Herrera; O F Herrán
Journal:  Epidemiol Infect       Date:  2017-09-14       Impact factor: 4.434

6.  Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome.

Authors:  Thi Phuong Lan Nguyen; Mihoko Kikuchi; Thi Que Huong Vu; Quang Ha Do; Thi Thuy Tran; Dinh Tham Vo; Manh Tuan Ha; Van Tuong Vo; Thi Phi Nga Cao; Van Dat Tran; Toshifumi Oyama; Kouichi Morita; Michio Yasunami; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2008-10-01

7.  Dengue and acute gingival bleeding.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Indian Soc Periodontol       Date:  2014-01

8.  A retrospective cohort study to predict severe dengue in Honduran patients.

Authors:  Eduardo Fernández; Marek Smieja; Stephen D Walter; Mark Loeb
Journal:  BMC Infect Dis       Date:  2017-10-11       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.